MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s1473-3099(23)00126-3

Медицинская библиотека · The Lancet. Infectious diseases · 2023

RTS,S/AS01 malaria vaccine-proven safe and effective?

Björkman Anders, Benn Christine Stabell, Aaby Peter, Schapira Allan

СтатьяОбзорПеревод пока не подготовлен

Аннотация

In October, 2021, WHO recommended that the RTS,S malaria vaccine, with its strong safety profile and high impact, be provided to children from age 5 months in regions with moderate to high Plasmodium falciparum malaria transmission. The evidence base included phase 3 trials in seven African countries and an ongoing malaria vaccine implementation programme (MVIP) in three African countries. We highlight problems with the MVIP mortality data, including potential confounding, inappropriate use of severe malaria as a surrogate marker, a statistically non-significant effect, and assessment after 2 years instead of the stipulated 4 years, which could have inflated the benefits and deflated the risks associated with the vaccine. We conclude that the claimed impact of the MVIP on mortality is not based on enough scientific evidence and that the MVIP findings do not rule out the possibility of increased mortality among vaccinated girls compared with vaccinated boys, as observed in the phase 3 studies. The MVIP should adhere fully to the planned analyses and the data should be made available for independent assessment. Roll-out of the vaccine elsewhere should include rigorous evaluation, especially of its safety.

Для цитирования: Björkman Anders, Benn Christine Stabell, Aaby Peter, Schapira Allan. RTS,S/AS01 malaria vaccine-proven safe and effective?. The Lancet. Infectious diseases. 2023. DOI: 10.1016/s1473-3099(23)00126-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.